Schedule 13G ownership disclosure

Regulus Therapeutics Inc.

Security class unavailable · CUSIP: 75915K101

Event date: 2017-05-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,117,144
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-17-000282
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 30, 2017
Reporting period
May 17, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub